Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.42 |
| ▸ | KIF11 | P52732 | 2/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | LAP3 | P28838 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18411356 | 0.94 | TSHR (0.50) | MMP3PTGS1TSHRCYP11B2ALDH1A1 | |
| SCHEMBL11557444 | 0.86 | HRH4 (0.44) | MMP3PTGS1TSHRCYP11B2KIF11 | |
| SCHEMBL26274413 | 0.84 | ABCG2 (0.50) | TSHRALDH1A1HRH4 | |
| SCHEMBL31463164 | 0.83 | TSHR (0.57) | MMP3PTGS1TSHRCYP11B2KIF11 | |
| SCHEMBL26592149 | 0.83 | ABCG2 (0.49) | CYP11B2 | |
| SCHEMBL11618139 | 0.83 | TSHR (0.52) | MMP3TSHRCYP11B2KIF11ALDH1A1 | |
| SCHEMBL12681320 | 0.82 | LOXL2 (0.46) | MMP3PTGS1TSHRCYP11B2KIF11 | |
| SCHEMBL28056373 | 0.82 | ALDH1A1 (0.43) | TSHRALDH1A1LAP3MAOBAR | |
| SCHEMBL26274420 | 0.82 | EGLN2 (0.43) | CYP11B2ALDH1A1CYP2A6HRH4AR | |
| SCHEMBL13192345 | 0.81 | IDO1 (0.39) | MMP3TSHRCYP11B2KIF11ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2456555-A1 | METHOD FOR OXIDIZING METHANE | Studiengesellschaft Kohle MbH (DE) | 2012-05-30 | — | — | EP | claimed |
| US-20120130071-A1 | METHOD FOR OXIDIZING METHANE | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2012-05-24 | — | — | US | claimed |
| WO-2011009429-A1 | METHOD FOR OXIDIZING METHANE | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2011-01-27 | — | — | WO | claimed |
| CN-109713327-A | A kind of non-precious metal catalyst and preparation method thereof | 中国科学院福建物质结构研究所 | 2019-05-03 | — | — | CN | disclosed |
| EP-2456555-A1 | METHOD FOR OXIDIZING METHANE | Studiengesellschaft Kohle MbH (DE) | 2012-05-30 | — | — | EP | disclosed |
| US-20120130071-A1 | METHOD FOR OXIDIZING METHANE | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2012-05-24 | — | — | US | disclosed |
| WO-2011009429-A1 | METHOD FOR OXIDIZING METHANE | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2011-01-27 | — | — | WO | disclosed |
| US-20100280216-A1 | METHOD OF PREPARING ORGANIC POROUS SOLIDS AND SOLIDS OBTAINABLE BY THIS METHOD | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2010-11-04 | — | — | US | disclosed |
| EP-2014699-B1 | Method of preparing organic porous solids and solids obtainable by this method | MAX PLANCK GESELLSCHAFT (DE) | 2009-09-02 | — | — | EP | disclosed |
| EP-2014699-A1 | Method of preparing organic porous solids and solids obtainable by this method | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2009-01-14 | — | — | EP | disclosed |
| WO-2008152147-A1 | METHOD OF PREPARING ORGANIC POROUS SOLIDS AND SOLIDS OBTAINABLE BY THIS METHOD | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120130071-A1 | METHOD FOR OXIDIZING METHANE | TST, MGMT, PMS2 | MMP3 3998/4885PTGS1 1700/4885TSHR 3773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.